London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Whatever happened to the research project with University of Oslo? Another dead end?
No unfortunately not. But now have funds to buy another 3 million so will jump in if the price drops.
Check this out from the guardian
Optimism about a potential treatment for Covid-19 gave a shot in the arm to stock markets around the world, amid claims that a drug called remdesivir has spurred rapid recovery in 113 patients.
A University of Chicago hospital participating in a study of the antiviral medication, made by US firm Gilead Sciences, found that nearly all patients suffering severe fever and respiratory symptoms were discharged within a week. A report of the study, issued by specialist healthcare publication Stat News shortly after Wall Street closed on Thursday night, spurred hopes among investors that lockdowns around the world could soon be eased.
Because it was you?
The delayed sell of 2 million was definitely a buy
Spot on Gixer. And bi-health will no doubt push really hard now for blue cap. But feel and other progress in Europe and USA will be on hold to 2021. Was able to buy earlier in the afternoon at 0.44 now 0.49. Dam, was going to buy another million shares to. Stay safe everyone
General disclosure of price sensitive information
11. An AIM company must issue notification without delay of any new developments which
are not public knowledge which, if made public, would be likely to lead to a significant
movement in the price of its AIM securities. By way of example, this may include matters
concerning a change in:
7
— its financial condition;
— its sphere of activity;
— the performance of its business; or
— its expectation of its performance.
Much as it would be nice to get an update on China, no news is good news IMO.
https://www.londonstockexchange.com/companies-and-advisors/aim/publications/rules-regulations/aim-rules-for-companies-march-2018.pdf
The last update was August 2019. This collaboration and its success is essential to Provexis. In view of Covid- 19, the company should have provided an update on the potential impact on the trials and applications. Other companies have updated shareholders as appropriate for their business. I did ask IF for an update but he hasn't given me the courtesy of a reply.
You keep on expecting an update when no update is due.
The essence of insanity is continuing to do the same thing whilst expecting a different outcome.
You may have heard on the news the hit to GDP suffered by China last quarter. By Health will undoubtedly be pausing product promotions at a time when incomes are suffering. the whole world will be firmly in recession for some time. But you expect business as usual. Why? What reason, other than impatience, can you attribute to your demands for IF to communicate to the market?
Pumpky, you're right. A certain poster seems to view every contrary opinion to his own as being driven by ulterior motives. He can't seem to accept that this is a company "managed" by a FD who is non-res and has never felt the need to communicate with the people who pay his very generous salary. Poorly run company wholly dependent on a venture with the decent and open Chinese (not) 10 years and still waiting for the elusive "major"!!
https://europepmc.org/article/ppr/ppr122220
Just popped up on google scholar
Background : Platelet can release lots of active molecules from granules in active state, which contributes to the progress of atherosclerosis and thrombosis. Fruitflow is a water-soluble tomato extract that has been reported to exert protective cardiovascular effects. The present study aims to investigate whether Fruitflow acts on human platelet granule secretion in vitro and further explore its underlying mechanisms. Methods: Recruit healthy volunteers to collect their peripheral blood and isolate gel-filtered platelets for in vitro experiments. Agonist-induced platelet granule secretion was detected by flow cytometry or ELISA kit. To elucidate the molecular mechanisms, the signaling pathway was tested by western blotting. Results: Fruitflow inhibited platelet surface expression of CD62P, CD40L, and CD63. Moreover, agonist-induced release of platelet factor 4 (PF4), ß-thromboglobulin (ß-TG), Regulated on Activation Normal T cell Expressed and Secreted (RANTES), transforming growth factor-ß1 (TGF-ß1), ATP, Ca 2+ , and serotonin were also significantly attenuated by Fruitflow. Furthermore, Fruitflow down-regulated expression of Lyn and phosphorylation of Src, LAT, Syk, PLC?2 and PKC. However, PKC inhibitor GF109203X did not show additive effects on platelet granule secretion when combined with Fruitflow. Conclusion: Fruitflow effectively inhibited platelet granule secretion via down-regulating platelet Src/PLC-?2/PKC signaling pathway in vitro , which may provide a novel evidence for the cardioprotective benefits of tomato.
W$
Looks like the monthly delta is settling at around 6000,
Bad trad timers, why on earth would I purchase shares in Pxs now? Obviously no news!!
Last year the update was delayed from June in to July.
So what it is that grumpy bad trade timers are expecting in April I don't know.
If there is nothing to say, say nothing.
Last news Dec 2019,4 months wages paid??
Just a rambling missive excusing the poor management of the Company. Many other Companies have found the time to update Shareholders so why can't IF get off his backside and update us bearing in mind that China is our future! Even you will have to admit that communication is historically appalling from PXS.
Well, since, as far as I know, the board is free to any poster, I'll ignore your instruction not to respond, and give my thoughts.
The current world situation has a material effect on Provexis that goes far beyond the selfish demands of an unwise timer of trades IMHO.
The attitude of the business community towards trading relationships with China may well have to be reviewed. Recent events have brought home the risks of relationships that are free trade from one party, but, at least part, state controlled on the other. How free By Health is, how open in their international engagements, how much influence they have to achieve approval from what is indisputably state control of products allowed to be sold, is open to question. Certainly I have read many reports of mutterings from many governments that there will be a price to be paid.
Whether or not this world event, totally and utterly beyond any management's ability to anticipate or control, could be a cause for delay, nobody knows.
For myself, the timing of one set of results matters very little. The big picture is of concern. Mostly though, my main thoughts are for a world gripped by fear and uncertainty, suffering and loss.
Be prepared for no news unless it's about a delay. That's the way this Company seems to operate. Newsletter today all about stress. LOL, as a lifer on here, I know all about stress!!
Rather than bland statements about stress(most lifers here know all about stress!) How about an update on the business? Alf, please don't respond.
Come on provexis, give us some GOOD Newc,we all need so cheerful News
Thanks Gixer. I stand corrected. So why no recent Buys and Sells info? It would be good to know what prompted the MM's to lower the price.
Australia banned short selling, maybe UK could do the same!!But no,how would the city survive
trades shown on this site are from 13th Feb
Way more bought than sold today but the SP Drops - How does one work than out ??
For a company whose future is wholly dependent on China, my point was totally valid. That you chose to personalise it(as usual) says more about you than me.